Partnerships

The two companies will allow users to safely manage their health data, enable doctors to privately communicate with patients, and offer telehealth services.

Under the deal, Novartis will use Qualcomm Life's connectivity solutions to power its next-gen connected Breezhaler, the inhaler for its COPD portfolio.

The two companies have created the platform that combines adherence and lung function measurement with medication management services.

The solution mimics an in-person exam to enable the physician communicating with a remote patient to see his/her health data in the CareSpan provider interface.

The companies will tap Watson's cognitive computing abilities to make sense of the data gathered on their respective platforms.

Medical professionals using both platforms will be able to easily sync their calendars and Electronic Health Records (EHRs).

Attendees will be challenged to make their time at CES healthy by taking at least 10,000 steps, the equivalent of 5 miles, each day of the show.

Blue Mesa's platform, Transform, uses technology as well as a dedicated health coach and support community to help users reach their personal health goals.

The two giants are looking to accelerate the development of digital health solutions for patients who could benefit from neuromodulation therapy.

The two parties will establish a new company, Verb Surgical, that aims to create smaller, smarter and more affordable robotic-assisted systems for surgery.